Rockefeller Capital Management L.P. Bio Rad Laboratories, Inc. Transaction History

Rockefeller Capital Management L.P.

$36 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	SELL	$418.69 - $503.0 $52,336 - $62,875	-125 Reduced 18.97%	534 $254,000
Q4 2022 Mar 06, 2023	SELL	$351.71 - $456.01 $21,102 - $27,360	-60 Reduced 8.34%	659 $276,000
Q3 2022 Nov 02, 2022	BUY	$412.59 - $563.26 $51,161 - $69,844	124 Added 20.84%	719 $299,000
Q2 2022 Aug 12, 2022	BUY	$463.67 - $597.16 $49,612 - $63,896	107 Added 21.93%	595 $294,000
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $586,993 - $822,934	-1,119 Reduced 69.63%	488 $274,000
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $12,050 - $13,509	-17 Reduced 1.05%	1,607 $1.21 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $69,717 - $87,531	-106 Reduced 6.13%	1,624 $1.21 Million
Q2 2021 Aug 10, 2021	SELL	$576.64 - $649.04 $215,663 - $242,740	-374 Reduced 17.78%	1,730 $1.11 Million
Q1 2021 May 11, 2021	BUY	$547.01 - $662.35 $8,752 - $10,597	16 Added 0.77%	2,104 $1.2 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $71,495 - $90,083	140 Added 7.19%	2,088 $1.22 Million
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $129,512 - $152,646	285 Added 17.14%	1,948 $1 Million
Q2 2020 Aug 12, 2020	BUY	$334.87 - $493.06 $455,758 - $671,054	1,361 Added 450.66%	1,663 $751,000
Q1 2020 May 12, 2020	BUY	$320.01 - $409.07 $29,120 - $37,225	91 Added 43.13%	302 $106,000
Q4 2019 Feb 07, 2020	BUY	$319.73 - $374.2 $1,598 - $1,871	5 Added 2.43%	211 $78,000
Q3 2019 Nov 12, 2019	BUY	$304.55 - $345.24 $57,864 - $65,595	190 Added 1187.5%	206 $69,000
Q2 2019 Aug 09, 2019	SELL	$286.93 - $312.59 $71,158 - $77,522	-248 Reduced 93.94%	16 $5,000
Q1 2019 May 10, 2019	BUY	$224.3 - $317.41 $59,215 - $83,796	264 New	264 $81,000

Others Institutions Holding BIO

# of Institutions

478

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account